SEC Comment Letter for Oncotelic Therapeutics, Inc. (OTLC) (CIK 0000908259) (OTLC) — Apr 25, 2008

Oncotelic Therapeutics, Inc. (OTLC) (CIK 0000908259)
Date: April 25, 2008 · CIK: 0000908259 · Accession: 0000000000-08-021285

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

April 25, 2008

Author

Jeffrey Riedler

Form

UPLOAD

Company

Oncotelic Therapeutics, Inc. (OTLC) (CIK 0000908259)

Letter

Mail Stop 6010 April 25, 2008 Richard Chin, M.D. President and Chief Executive Officer Oxigene, Inc. 230 Third Avenue Waltham, MA 02451 Re: Oxigene, Inc. Preliminary Proxy Statement on Schedule 14A Filed April 18, 2008 File No. 0-21990 Dear Dr. Chin:

We have completed our review of your proxy statement and have no further comments at this time. Please contact Song Brandon at (202) 551-3621 with any questions. S i n c e r e l y , J e f f r e y R i e d l e r A s s i s t a n t D i r e c t o r cc: Megan N. Gates, Esq. Asya S. Alexandrovich, Esq. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. One Financial Center Boston, MA 02111

Show Raw Text

Mail Stop 6010        April 25, 2008  Richard Chin, M.D.  President and Chief Executive Officer Oxigene, Inc.  230 Third Avenue Waltham, MA  02451
Re:   Oxigene, Inc.
  Preliminary Proxy Statement on Schedule 14A
Filed April 18, 2008
  File No. 0-21990
Dear Dr. Chin:

We have completed our review of your proxy statement and have no further comments at
this time.  Please contact Song Brandon at (202) 551-3621 with any questions.         S i n c e r e l y ,            J e f f r e y  R i e d l e r         A s s i s t a n t  D i r e c t o r    cc: Megan N. Gates, Esq.   Asya S. Alexandrovich, Esq.   Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.   One Financial Center  Boston, MA  02111

SecProbe.io